LuxCMA – Luxembourg Capital Markets Association
This publication aims to provide detailed insights and actionable recommendations to simplify and improve the account opening process by proposing a minimum KYC approach for share capital accounts.
This comprehensive paper dives deep into the delves into the detailed world of structured products, providing invaluable insights for board members navigating financial complexities.ย
This new publication aims to provide clarity and advice to stakeholders using the financial statements of Financial Vehicle Corporations (FVCs). It also aims to harmonise the level of disclosure in the financial statements of FVCs across the market.
You'll have noticed! Non-performing loans (NPLs) are one of the hottest topics in the capital markets sphere at the moment, following the recent adoption of the relevant directive by the European Union. Today, our Best Practice I Management & Corporate Governance subgroup is therefore pleased to share with you its Guidance Note on Securitisation of Non-Performing Loans!
We are pleased to share with you today our latest documentย ๐๐๐ถ๐ฑ๐ฎ๐ป๐ฐ๐ฒย ๐ก๐ผ๐๐ฒย ๐ณ๐ผ๐ฟย ๐๐ผ๐ฎ๐ฟ๐ฑย ๐ ๐ฒ๐บ๐ฏ๐ฒ๐ฟ๐ย focusing on ๐๐ถ๐ฟ๐ฒ๐ฐ๐ย ๐น๐ฒ๐ป๐ฑ๐ถ๐ป๐ดย ๐๐ถ๐๐ตย ๐ฆ๐ฒ๐ฐ๐๐ฟ๐ถ๐๐ถ๐๐ฎ๐๐ถ๐ผ๐ปย ๐ฉ๐ฒ๐ต๐ถ๐ฐ๐น๐ฒย ๐ฎ๐ย ๐ผ๐ฟ๐ถ๐ด๐ถ๐ป๐ฎ๐๐ผ๐ฟ. Main parties involved, lending process and much more! Dive in this paper and find all the answers to your questions.
We are pleased to announce today the release of our latest publication on ๐ฆ๐ฒ๐ฐ๐๐ฟ๐ถ๐๐ถ๐๐ฎ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐ฅ๐ฒ๐ฐ๐ฒ๐ถ๐๐ฎ๐ฏ๐น๐ฒ๐. This is a timely topic as companies look for innovative solutions to manage their cash flow and liquidity in these challenging times. In this guidance note, our Best Practice I ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐ & ๐๐ผ๐ฟ๐ฝ๐ผ๐ฟ๐ฎ๐๐ฒ ๐๐ผ๐๐ฒ๐ฟ๐ป๐ฎ๐ป๐ฐ๐ฒ sub-group looks at the complex world of securitisation and how it can be leveraged to unlock the value of receivables. Mechanism, parties involved and more! Dive in it and find practical guidance on how companies can navigate this potentially game-changing financing option for many businesses. Thank you to our LuxCMA contributors for joining the conversation on this important topic. Feel free to share this publication with your colleagues and network! And if you have any questions, suggestions or comments, please feel free to contact us at info@luxcma.lu.
A new tool is now available for the LuxCMA community! Youโre still unsure of precisely what you must disclose and when โ it is high time to figure it out! Luckily, you donโt have to pull an all-nighter trying to make sense of it. In this timeline, our Best Practice I Management & Corporate Governance sub-group has listed what you have to disclose and when to make sure youโre compliant with the annual reporting deadlines for securitisation vehicles. What you have to do and when? Letยดs have a look!
Our Best Practice I UBO identification & KYC sub-group has been working over the last few months on the preparation of a guidance note on the identification of the beneficial owner(s) for the purposes of filing with the RBE with respect to orphan securitisation vehicles. This paper addresses the question of who should be reported as the Ultimate Beneficial Owner (โUBOโ) or Controller of a Financial Vehicle Corporation and aims to provide guidance on the steps to be taken in this process.
It is already a good start into the year! New document available for our followers! After the publication of the Best Practice Guidance Note on Performing loans and other receivables in mid-December, our Best Practice I Accounting & Reporting has a new gift for you! Check out today the Guidance Note focusing on the accounting methodology and different treatments for Repackaging of investment funds.
And finally here we are! New document available for our followers! Our Best Practice I Accounting & Reporting working group starts its gift distribution by releasing today its Guidance Note on Performing loans and other receivables accessible to all #LuxCMA followers on our website. The publication touches some interesting points regarding the accounting policy and the different treatments which apply to these receivables.